Fasenra (benralizumab) may provide fast and meaningful benefits for people with severe eosinophilic granulomatosis with polyangiitis (EGPA) who test negative for self-reactive antibodies called ANCAs, according to a small real-world case series. In all three reported cases, AstraZeneca’s treatment resulted in a fast and complete depletion of eosinophils,…
Discussion
People with ANCA-associated vasculitis (AAV) and severe kidney damage did not see better kidney outcomes with rituximab plus Tavneos (avacopan) than with rituximab alone, a study found. However, the results showed that adding Tavneos to rituximab may help limit the use…
Discussion
Has the following scenario ever happened to you? Test results come back normal, but you know something’s off. Personally, I’ve learned how to feel the inflammation and disease in my body. I know when it is active, even if lab results don’t tell that story. Most people would consider normal test…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
